JAKARTA (The Straits Times/ANN): With its own phase three clinical trial of a Covid-19 vaccine candidate in limbo, Indonesia said it has asked for data from Brazil, where a similar trial is progressing smoothly.
It expects to receive the safety and efficacy data on Chinese firm Sinovac Biotech's CoronaVac by Dec 28, and hopes to finally start rolling out its vaccination programme in January.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
